Abstract:Abstract Background: Congenital heart disease (CHD) is an important birth defect, but its mechanism is still unclear. In recent years, genetic causes including chromosomal abnormalities are associated with the occurrence of congenital heart disease. In this study, CMA technology is applied to explore the genetic causes of congenital heart disease, so as to further clarify the correlation between genotype and phenotype and prepare for late pregnancy intervention and postnatal diagnosis and treatment.Objective: To explore the chromosomal abnormalities and copy number variation (CNVs) of fetuses with CHD by CMA technology, and to clarify the clinical application value of CMA technology as a detection method of first-tier antenatal CHD.Methods: Amniotic fluid sample from 155 pregnant women diagnosed with fetus CHD by prenatal ultrasound from 2018 to 2021 are collected for SNP-array detection and karyotype analysis. According to the detected CNVs results, FISH, CMA or karyotype analysis are further selected for parental verification.Results: Among the 155 fetuses with CHD, a total of 32 (20.6%) cases of chromosomal abnormalities are detected, of which 31.3% are chromosome number abnormalities. CNVs of likely pathogenicity and unknown significance are 2.5% and 5.2% respectively. The detection rate of chromosomal abnormalities in CHD of different subtypes is different, among which the high detection rate is complex CHD (31.2%), right ventricular outflow tract obstruction (30.7%) and conotruncal defects (25%). The detection rate of chromosomal abnormalities in CHD with extracardiac structural abnormalities is significantly higher than that in isolated CHD (52.4% vs 11.3%, p<0.05). In addition, the detection rate of CHD with abnormal extracardiac structure is significantly higher than that of CHD with soft markers (52.4% vs 17.8%, p<0.05), which is statistically significant. There is no significant difference in detection rate between CHD with soft markers and isolated CHD (17.8% vs 11.3%). Of the 155 pregnant women with fetus CHD, 59 chose to terminate their pregnancies, some of which were terminated according to the results of SNP-array, and some of which were terminated according to the severity of CHD.Conclusion: SNP-array technology can be used to detect chromosomal abnormalities of first-tier antenatal CHD fetuses, with high resolution, short reporting period and high efficiency. Meanwhile, pregnancy intervention can be taken according to the results.

Placental DNA Methylation Abnormalities in Prenatal Conotruncal Heart Defects

Genome-wide Methylation Analysis Reveals Differentially Methylated CpG Sites and Altered Expression of Heart Development-Associated Genes in Fetuses with Cardiac Defects

The CpG Island Methylation Status Analysis in the Promoter Region of the Conotruncal Heart Malformation Candidate Gene NKX2-5

EP06.06: Analysis of Copy Number Variations in Fetal Conotruncal Heart Defects Using Low‐coverage Whole Genome Sequencing

Non-invasive Prenatal Testing Reveals Copy Number Variations Related to Pregnancy Complications

Abnormal Placental DNA Methylation Variation in Spontaneous Preterm Birth

Genome-wide DNA methylation analysis of discordant monozygotic twins reveals consistent sites of differential methylation associated with congenital heart disease

The Interaction Analysis of SNP Variants and DNA Methylation Identifies Novel Methylated Pathogenesis Genes in Congenital Heart Diseases

Placental epigenetics for evaluation of fetal congenital heart defects: Ventricular septal defect (VSD)

Screening Significantly Hypermethylated Genes in Fetal Tissues Compared with Maternal Blood Using a Methylated-Cpg Island Recovery Assay-Based Microarray

DNA Methylome Profiling of Maternal Peripheral Blood and Placentas Reveal Potential Fetal DNA Markers for Non-Invasive Prenatal Testing.

Hypomethylated Dscr4 Is A Placenta-Derived Epigenetic Marker For Trisomy 21

Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

Relationship of Methylation Within Upper Stream Region of Transcription Starts Site of HOXA5 Gene with Neural Tube Defects.

DNA Methylation Profiles in Placenta and Its Association with Gestational Diabetes Mellitus.

Fetal DNA Hypermethylation in Tight Junction Pathway is Associated with Neural Tube Defects: A Genome-Wide DNA Methylation Analysis

Clinical Application of Chromosomal Microarray Analysis in Fetuses with Congenital Heart Disease

DNA methylation of the Lamin A/C gene is associated with congenital heart disease

Comparison of DNA Methylation Profiles Associated with Spontaneous Preterm Birth in Placenta and Cord Blood

Tissue-specific Distribution of Aberrant DNA Methylation Associated with Maternal Low-Folate Status in Human Neural Tube Defects

Prenatal detection of novel compound heterozygous variants of the PLD1 gene in a fetus with congenital heart disease